📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). (2024)

First Author: Scullion KM
Attributed to:  MICA: Point-of-care assessment of drug-induced liver injury (POC-DILI) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/toxsci/kfae031

PubMed Identifier: 38521541

Publication URI: http://europepmc.org/abstract/MED/38521541

Type: Journal Article/Review

Volume: 199

Parent Publication: Toxicological sciences : an official journal of the Society of Toxicology

Issue: 2

ISSN: 1096-0929